2014
DOI: 10.4269/ajtmh.14-0210
|View full text |Cite
|
Sign up to set email alerts
|

Quantification of Plasmodium falciparum Histidine-Rich Protein-2 in Cerebrospinal Spinal Fluid from Cerebral Malaria Patients

Abstract: Abstract. A cerebrospinal fluid (CSF) biomarker for cerebral malaria (CM) has not been validated. We examined the detection, semiquantification, and clinical use of the Plasmodium falciparum histidine-rich protein-2 (PfHRP-2) as a parasite antigen biomarker for CM. The PfHRP-2 was detected in archival CSF samples from CM patients from Tanzania both by a newly developed sensitive and specific immuno-polymerase chain reaction (72 of 73) and by rapid diagnostic tests (62 of 73). The geometric mean PfHRP-2 CSF con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
8
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 26 publications
0
8
0
Order By: Relevance
“…Estimation of Plasmodium falciparum histidine rich protein 2 (PfHRP2) in the plasma samples has also been shown to be an accurate diagnostic tool to ascertain the parasite biomass in severe malaria patients, and allowed the distinction between severe and uncomplicated malaria (Hendriksen et al, 2012 ; Imwong et al, 2015 ). Clinical studies have also shown that PfHRP2 can be present in the CSF of patients with CM (Mikita et al, 2014 ). More recently, the use of advanced affinity-proteomic tools employing a high-throughput platform of specific antibodies for candidate screening has allowed a wider analysis of potential diagnosis biomarkers for the neuropathology.…”
Section: Biomarkersmentioning
confidence: 99%
“…Estimation of Plasmodium falciparum histidine rich protein 2 (PfHRP2) in the plasma samples has also been shown to be an accurate diagnostic tool to ascertain the parasite biomass in severe malaria patients, and allowed the distinction between severe and uncomplicated malaria (Hendriksen et al, 2012 ; Imwong et al, 2015 ). Clinical studies have also shown that PfHRP2 can be present in the CSF of patients with CM (Mikita et al, 2014 ). More recently, the use of advanced affinity-proteomic tools employing a high-throughput platform of specific antibodies for candidate screening has allowed a wider analysis of potential diagnosis biomarkers for the neuropathology.…”
Section: Biomarkersmentioning
confidence: 99%
“…IHC using monoclonal antibody 3A4 [ 14 , 15 ] to P. falciparum histidine-rich protein 2 (HRP2) was carried out on 5 mm thick, formalin-fixed, paraffin-embedded sections using automated IHC stainer (Bond Leica, Leica Microsystems, Bannockburn, IL, USA) at the Johns Hopkins Immunopathology Research Laboratory as previously described [ 16 ]. Slides were deparaffinized and hydrated, and heat-induced antigen retrieval step was performed using citrate buffer (pH 6.0).…”
Section: Methodsmentioning
confidence: 99%
“…This study therefore focuses on the measurement of PfHRP-2 in the CSF compartment. PfHRP-2 has previously been quantified in the CSF of patients with CM, though samples in this previous study were obtained without information on malaria retinopathy status [ 27 ]. Here, the authors report quantitative CSF PfHRP-2 levels in a cohort of retinopathy-positive CM children to determine whether there is a relationship between CSF PfHRP-2 and clinical, laboratory and radiographic features of interest.…”
Section: Introductionmentioning
confidence: 99%